A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Mild Allergic Diseases
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the safety, tolerability, pharmacokinetic (PK) and
pharmacodynamic (PD) profiles following multiple subcutaneous injections of YH35324 in
healthy subjects or subjects with mild allergic diseases, who have atopy.